Roth Capital Initiates Marathon Patent Group At Buy

Roth Capital initiated coverage on

with a Buy rating. The target price for Marathon Patent Group is set to $12. Marathon Patent Group shares have gained 60.45 percent over the past 52 weeks, while the S&P 500 index has surged 10.86 percent in the same period. Marathon Patent Group's shares rose 0.44 percent to close at $5.76 yesterday.